General Information
Revision date
2022-12-13
Product name
Thromboclotin
1.2.1 Relevant identified uses
Diagnostic agents
supplier name
Siemens Healthcare Diagnostics Limited
Emergency telephone
+44 20 3807 3798
Icons in SDS
Company Information
company name
Siemens Healthcare Diagnostics Limited
e-mail address of the competent person responsible for the Safety Data Sheet
dx.msds.healthcare@siemens-healthineers.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Product definition
Mixture Classification according to UK CLP/GHS Resp. Sens. 1, H334
Signal word
Danger
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Prevention
P261 - Avoid breathing dust.
Response
P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor. P304 - IF INHALED: P340 - Remove person to fresh air and keep comfortable for breathing.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
Additional information
Potentially biohazardous material. Not available.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to UK CLP/GHS Resp. Sens. 1, H334 The product is classified as hazardous according to UK CLP Regulation SI 2019/720 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
